These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 25252176

  • 1. Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.
    Salhi HE, Walton SD, Hassel NC, Brundage EA, de Tombe PP, Janssen PM, Davis JP, Biesiadecki BJ.
    J Mol Cell Cardiol; 2014 Nov; 76():257-64. PubMed ID: 25252176
    [Abstract] [Full Text] [Related]

  • 2. Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment.
    Nixon BR, Walton SD, Zhang B, Brundage EA, Little SC, Ziolo MT, Davis JP, Biesiadecki BJ.
    J Mol Cell Cardiol; 2014 Jul; 72():177-85. PubMed ID: 24657721
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.
    Nixon BR, Thawornkaiwong A, Jin J, Brundage EA, Little SC, Davis JP, Solaro RJ, Biesiadecki BJ.
    J Biol Chem; 2012 Jun 01; 287(23):19136-47. PubMed ID: 22493448
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity.
    Lin YH, Schmidt W, Fritz KS, Jeong MY, Cammarato A, Foster DB, Biesiadecki BJ, McKinsey TA, Woulfe KC.
    J Mol Cell Cardiol; 2020 Feb 01; 139():135-147. PubMed ID: 31981571
    [Abstract] [Full Text] [Related]

  • 8. Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
    Bayliss CR, Jacques AM, Leung MC, Ward DG, Redwood CS, Gallon CE, Copeland O, McKenna WJ, Dos Remedios C, Marston SB, Messer AE.
    Cardiovasc Res; 2013 Mar 01; 97(3):500-8. PubMed ID: 23097574
    [Abstract] [Full Text] [Related]

  • 9. Calcium- and magnesium-dependent interactions between the C-terminus of troponin I and the N-terminal, regulatory domain of troponin C.
    Digel J, Abugo O, Kobayashi T, Gryczynski Z, Lakowicz JR, Collins JH.
    Arch Biochem Biophys; 2001 Mar 15; 387(2):243-9. PubMed ID: 11370847
    [Abstract] [Full Text] [Related]

  • 10. The lack of Troponin I Ser-23/24 phosphorylation is detrimental to in vivo cardiac function and exacerbates cardiac disease.
    Salhi HE, Shettigar V, Salyer L, Sturgill S, Brundage EA, Robinett J, Xu Z, Abay E, Lowe J, Janssen PML, Rafael-Fortney JA, Weisleder N, Ziolo MT, Biesiadecki BJ.
    J Mol Cell Cardiol; 2023 Mar 15; 176():84-96. PubMed ID: 36724829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myofilament Calcium Sensitivity: Consequences of the Effective Concentration of Troponin I.
    Siddiqui JK, Tikunova SB, Walton SD, Liu B, Meyer M, de Tombe PP, Neilson N, Kekenes-Huskey PM, Salhi HE, Janssen PM, Biesiadecki BJ, Davis JP.
    Front Physiol; 2016 Mar 15; 7():632. PubMed ID: 28066265
    [Abstract] [Full Text] [Related]

  • 16. Ca2+, pH and the regulation of cardiac myofilament force and ATPase activity.
    Solaro RJ, el-Saleh SC, Kentish JC.
    Mol Cell Biochem; 1989 Sep 07; 89(2):163-7. PubMed ID: 2530435
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylation of Troponin I finely controls the positioning of Troponin for the optimal regulation of cardiac muscle contraction.
    Kachooei E, Cordina NM, Potluri PR, Guse JA, McCamey D, Brown LJ.
    J Mol Cell Cardiol; 2021 Jan 07; 150():44-53. PubMed ID: 33080242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca2+-desensitizer.
    Wong S, Feng HZ, Jin JP.
    J Mol Cell Cardiol; 2019 Nov 07; 136():42-52. PubMed ID: 31505197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.